Cargando…

Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review

Evidence from clinical, preclinical, and post-mortem studies supports the inflammatory/immune hypothesis of schizophrenia pathogenesis. Less evident is the link between the inflammatory background and two well-recognized functional and structural findings of schizophrenia pathophysiology: the dopami...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Bartolomeis, Andrea, Barone, Annarita, Vellucci, Licia, Mazza, Benedetta, Austin, Mark C., Iasevoli, Felice, Ciccarelli, Mariateresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463235/ https://www.ncbi.nlm.nih.gov/pubmed/35963926 http://dx.doi.org/10.1007/s12035-022-02976-3

Ejemplares similares

Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal
por: Iasevoli, Felice, et al.
Publicado: (2023)

Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
por: De Simone, Giuseppe, et al.
Publicado: (2023)

Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2023)

Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance
por: de Bartolomeis, Andrea, et al.
Publicado: (2022)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2023)

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted
por: Iasevoli, Felice, et al.
Publicado: (2020)

O9.4. RELATIONSHIPS BETWEEN AGE AT ONSET OF PSYCHOTIC SYMPTOMS AND POOR RESPONSE TO ANTIPSYCHOTICS IN A SAMPLE OF TRS/NON-TRS PATIENTS
por: Iasevoli, Felice, et al.
Publicado: (2020)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
por: Vellucci, Licia, et al.
Publicado: (2023)

S228. TOWARD EARLY DETECTION OF TREATMENT RESISTANT SCHIZOPHRENIA: PREDICTIVE INFORMATION ON NON-RESPONSE TO ANTIPSYCHOTICS BY EVALUATION OF A FEW CLINICAL FACTORS: A STUDY BY ROC CURVE ANALYSIS AND CONFIRMATORY MULTIVARIATE ANALYSIS
por: Iasevoli, Felice, et al.
Publicado: (2018)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration
por: Barone, Annarita, et al.
Publicado: (2023)

S205. A TRANSLATIONAL HOMER 1A-BASED NETWORK APPROACH: IMAGING HOW HALOPERIDOL MODULATES GLUTAMATE SYSTEM FUNCTIONAL CONNECTIVITY
por: Vellucci, Licia, et al.
Publicado: (2020)

F234. TYPICAL AND ATYPICAL ANTIPSYCHOTICS’ D2R AFFINITY AND DOSES INFLUENCES POSTSYNAPTIC DENSITY BY MODULATING THE SPATIAL EXPRESSION OF HOMER1A A GENE HIGHLY IMPLICATED IN SYNAPTIC PLASTICITY AND PSYCHOSIS
por: Camilla, Avagliano, et al.
Publicado: (2018)

Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study
por: Tranfa, Mario, et al.
Publicado: (2023)

Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
por: de Bartolomeis, Andrea, et al.
Publicado: (2015)

Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
por: de Bartolomeis, Andrea, et al.
Publicado: (2022)

Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
por: Iasevoli, Felice, et al.
Publicado: (2021)

PM437. Spatial and temporal modulation of Homer1a gene expression at the post-synaptic density is related to D2R affinity and dose of antipsychotics: translational considerations for schizophrenia treatment strategies.
por: de Bartolomeis, Andrea, et al.
Publicado: (2016)

M139. DIFFERENTIAL PATTERNS OF BRAIN METABOLISM IN STABILIZED, ACTIVELY SYMPTOMATIC TREATMENT RESISTANT VS. TREATMENT RESPONDER SCHIZOPHRENIA PATIENTS: A STUDY BY 18F-FDG-POSITRON EMISSION TOMOGRAPHY AND STRUCTURAL 3T MRI
por: Iasevoli, Felice, et al.
Publicado: (2020)

F233. NEGATIVE SYMPTOMS ARE INDEPENDENT MODERATOR FACTORS OF TREATMENT RESISTANT SCHIZOPHRENIA EFFECTS ON MULTIPLE CLINICAL, PSYCHOPATHOLOGICAL, COGNITIVE AND PSYCHOSOCIAL VARIABLES
por: Iasevoli, Felice, et al.
Publicado: (2018)

Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
por: Iasevoli, Felice, et al.
Publicado: (2018)

M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA
por: Barone, Annarita, et al.
Publicado: (2020)

Beyond Dopamine: Glutamate as a Target for Future Antipsychotics
por: Sendt, Kyra-Verena, et al.
Publicado: (2012)

Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
por: Tomasetti, Carmine, et al.
Publicado: (2017)

S77. ROLE OF DOPAMINE AND GLUTAMATE TRANSPORTERS IN GENERATION OF ANTIPSYCHOTIC EFFICACY
por: Kruyer, Anna, et al.
Publicado: (2020)

Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes
por: de Bartolomeis, Andrea, et al.
Publicado: (2017)

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
por: Iasevoli, Felice, et al.
Publicado: (2014)

Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
por: Iasevoli, Felice, et al.
Publicado: (2013)

The effects of sustained COVID‐19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study
por: Barone, Annarita, et al.
Publicado: (2022)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study
por: Iasevoli, Felice, et al.
Publicado: (2014)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
por: Egerton, Alice, et al.
Publicado: (2020)

Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies
por: Panariello, Fabio, et al.
Publicado: (2011)

Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia
por: Savushkina, Olga K., et al.
Publicado: (2020)

Co-transmission of dopamine and glutamate
por: Broussard, John I.
Publicado: (2012)

History of the dopamine hypothesis of antipsychotic action
por: Seeman, Mary V
Publicado: (2021)

Predicting the Severity of Lockdown-Induced Psychiatric Symptoms with Machine Learning
por: D’Urso, Giordano, et al.
Publicado: (2022)

Search for novel antipsychotic drugs: dopamine forever?
por: Gyertyán, István
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1ac8b1lk5rvkblnheptlpqas25